Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'd hate to see that this is just another StockRoom pump-n-dump based on the remaining anticipation about this stock. But you can never be sure. I would love to think someone has legit information!
Still showing:
Dark or Defunct
Caveat Emptor
Transfer Agent Verified
Prohibited Service Provider
Even if it costs BP millions in $ losses to keep CYDY down, it pays them to do so for as long as possible.
My theory:
1. Leronlimab works amazingly with a very strong safety profile.
2. This makes it attractive to the medical profession.
3. It has multiple indications.
4. This makes it attractive to the medical profession.
5. Demand for certain other drugs will be reduced significantly if Leronlimab is approved for the indications it has trialed for.
6. This makes it attractive to the medical profession.
7. Large (other) Pharma do not like to see money flow from their coffers to others (standard business practice).
8. CYDY will soon be uplisted to Nasdaq, which bring certain benefits with it that will positively affect the company's ability to continue to test Leronlimab.
9. The drugs of other Pharma companies are under greater threat for reduced revenue the closer CYDY gets to approvals and uplisting.
10. One way to negatively affect CYDY is to have your favorite hired gun short the hell out of it at every turn, or at least at strategic places in the development process.
11. I think this is likely what is happening now, whether or not it is what happened back in June's run up.
12. Summary: the effectiveness of Leronlimab across multiple indications and the imminent Nasdaq uplisting are strong motives for certain companies whose revenues may be affected by Leronlimab approvals to engage in shorting. Do I have video evidence of any particular group shorting this stock today? No. Is it likely? Yes.
Is it that you don't believe stocks get shorted or that this stock is currently being shorted?
The level of shorting here ought to tell you all you need to know about efficacy! LOL Relentless = scared sh*tless!
Well-said! I agree. Corporate greed and little bureaucrats being handed nice Xmas presents for their cooperation . . .
Yeah, that's a bit of a problem for OTC Markets . . . for whom I do not have the highest quality of trust. The CE virtually guarantees that they either 1) failed to do the proper investigation to determine that it was in fact the company they had listed who was posting information publicly without filing proper paperwork through the proper channels or 2) or are confirming the legitimacy of the tweets by posting the CE after no filing or PR within 4 business days.
The original ARCS website before it went "under construction":
https://web.archive.org/web/20201208164340/https://www.arcisresourcescorp.com/
I don't remember who posted this link or I would give them credit.
I've read this board enough to know what many of you think.
I, however, will never be convinced that some of the BP are paying someone(s) to short the hell out of this due to fear of Leronlimab taking away significant revenues from their currently approved drugs.
Yes, I was off by a week, as noted in my earlier response to another poster.
Do any of you know if the company has any currently enrolling or plans to begin a study for rheumatoid arthritis?
My bad . . . too much something under the bridge . . . ! Whew! Seem like a week!
We got CE'd on the evening of 12/10 and slammed down on the morning of 12/11. The modification of the website took place the next day, Saturday 12/12.
FWIW - TOS is also showing the 435M number . . .
So did our resident techno brainiacs decide that this website that claims to be "under construction" and "bring you the good stuff" is legit and owned by the real Arcis Resources Corp. . . . whoever the hell that may actually be?
https://www.arcisresourcescorp.com
If you go to the page and right click then select "page info" you can see it was modified on:
Saturday, December 12, 2020, 2:26:48 PM
But, they are a "for-profit" corporation, which, as I'm sure you know, does whatever is best for the bottom line, which may or may not be maintaining "legit" status 24/7. They have tools that can be used to make lots and lots of money . . . so, there's bound to be corruption in there somewhere. It's just human nature, especially American corporate nature.
Those are EST right?
That is sourceless verification, which I find disturbing. So, I have emailed the good folks at West Coast Stock Transfer to get more information about this process. I've had enough of the old "trust the internet cause . . . well, it's on the internet" BS to last me 43 lifetimes.
This verification takes place outside the documentary process?
What documents is OTC Markets using to support this share structure? I don't see any filings, so how do they know this supposed dilution has happened?
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 346,357,400 shares of common stock as of August 8, 2019.
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 435,482,400 shares of common stock as of August 4, 2020.
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 435,482,400 shares of common stock as of August 4, 2020.
Only 435M or so outstanding shares . . . crazy low for trips!
I've often thought something along those lines. Nice to hear someone else say it!
The problem is, and I posted my position on this a few days ago, they provide no hard data or reasoning for the CE. The CE notice simply gives a list of "possibilities," one of which is listed for ARCS:
Warning! This company may not be making material information publicly available
Buying or selling a security on the basis of material nonpublic material information is prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators may be subject to civil and criminal penalties.
CDEL has been doing that for at least ten days here.
The SEC did not put Caveat Emptor on ARCS. That was done by the private for-profit corporation called OTC Markets.
I'm just trying to verify the float . . . someone thinks everything out here is a scam . . . .
This is the one I posted this morning and several other posters said they could access it also.
https://twitter.com/ARCS_corp
I have no idea what that means
Was that a "no"?
332K tradable shares?
More short term, need to break .0032 to move on up today.
Looks like CDEL has a big buyer "buy all you can get at .0027"
Does this someone have tens of millions of shares of this company? That would be a really good sign that s/he believes what s/he is telling you.
While I don't doubt that either of you are "hearing things" . . . are the things you are hearing from sources you consider credible? You both know what throwing these kinds of statements onto a board like this at at time like this does.
Deleted vs. "sell only" is very different. Who are you selling to?
https://twitter.com/ARCS_corp
Does this link work for you?